Crown Bioscience, a leading global provider of preclinical and translational research services, is headquartered in the United States. Founded in 2006, the company has established itself as a key player in the biotechnology and pharmaceutical industries, specialising in oncology, immunology, and metabolic diseases. With operational facilities across North America, Europe, and Asia, Crown Bioscience offers a comprehensive suite of services, including in vivo models, biomarker analysis, and drug efficacy testing. What sets Crown Bioscience apart is its commitment to innovation and quality, providing clients with tailored solutions that accelerate drug development. The company has achieved significant milestones, including partnerships with major pharmaceutical firms and contributions to numerous successful clinical trials. As a trusted partner in the life sciences sector, Crown Bioscience continues to enhance its market position through cutting-edge research and a robust portfolio of unique services.
We don't have data for Crown Bioscience, but we can show you information about their parent organization instead.
View parent company